Entera Bio Ltd. (ENTX)

Entera Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	0.13	0.57	0.37	0.24
Revenue Growth (YoY)	-	-76.53%	56.44%	54.66%	-52.80%
Cost of Revenue	0	0.1	0.37	0.3	0.21
Gross Profit	0	0.03	0.2	0.07	0.03
Selling, General & Admin	4.43	7.25	5.69	4.85	4.28
Research & Development	4.51	5.85	6.77	6.38	7.2
Operating Expenses	8.94	13.1	12.46	11.23	11.48
Operating Income	-8.94	-13.07	-12.26	-11.17	-11.45
Other Expense / Income	-0.08	-0.13	-0.02	0.03	-0.66
Pretax Income	-8.86	-12.93	-12.25	-11.2	-10.8
Income Tax	0.03	0.14	-0.06	0.02	0
Net Income	-8.89	-13.07	-12.19	-11.22	-10.8
Shares Outstanding (Basic)	29	29	26	18	12
Shares Outstanding (Diluted)	29	29	26	18	12
Shares Change	0.69%	10.23%	41.90%	51.62%	52.15%
EPS (Basic)	-0.31	-0.45	-0.47	-0.67	0.89
EPS (Diluted)	-0.31	-0.45	-0.47	-0.67	0.89
EPS Growth	-	-	-	-	-32.06%
Free Cash Flow	-7.33	-12.55	-9.08	-10.61	-8.96
Free Cash Flow Per Share	-0.25	-0.44	-0.35	-0.58	-0.74
Gross Margin	-	24.63%	34.68%	17.81%	11.02%
Operating Margin	-	-9752.24%	-2147.64%	-3059.73%	-4853.39%
Profit Margin	-	-9754.48%	-2134.33%	-3072.88%	-4574.15%
Free Cash Flow Margin	-	-9362.69%	-1590.19%	-2906.85%	-3796.19%
EBITDA	-8.8	-12.87	-12.19	-11.13	-10.56
EBITDA Margin	-	-9604.48%	-2135.38%	-3050.14%	-4473.31%
Depreciation & Amortization	0.06	0.06	0.05	0.06	0.24
EBIT	-8.86	-12.93	-12.25	-11.2	-10.8
EBIT Margin	-	-9652.24%	-2144.66%	-3067.40%	-4574.15%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).